OTCMKTS:LPHM Lee Pharmaceuticals (LPHM) Stock Price, News & Analysis → Here’s how to start a “Weekend Side Hustle” from your sofa (From DTI) (Ad) Free LPHM Stock Alerts $0.0006 0.00 (0.00%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$0.0002▼$0.000950-Day Range N/A52-Week Range$0.01▼$0.40Volume135.72 million shsAverage Volume54,707 shsMarket Capitalization$21,097.20P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsStock AnalysisChartFinancialsHeadlinesSEC Filings Get Lee Pharmaceuticals alerts: Email Address Ad DTIHere’s how to start a “Weekend Side Hustle” from your sofaHere’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand.Weekend after weekend! About Lee Pharmaceuticals Stock (OTCMKTS:LPHM)Lee Pharmaceuticals, Inc., through its subsidiary, RONN Motor Group, Inc., focuses on the design and development, manufacture, marketing, and sale of all-electric, hydrogen-fuel cell, and zero-emission new energy vehicles (NEVs) in the United States, China, and internationally. It intends to offer hydrogen fuel cell NEVs, including sports cars, sedans, SUVs, trucks, and buses. The company was founded in 2013 and is based in Scottsdale, Arizona.Read More LPHM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LPHM Stock News HeadlinesApril 15, 2024 | msn.comSingapore PM Lee to hand power to successor Wong on May 15April 13, 2024 | americanbankingnews.comLee Pharmaceuticals (OTCMKTS:LPHM) vs. Haleon (NYSE:HLN) Head-To-Head ContrastApril 23, 2024 | Wealthpin Pro (Ad)One trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? February 10, 2024 | nypost.com5th Kansas City Chiefs fan at party where 3 friends were later found frozen to death ID’d: reportFebruary 7, 2024 | reuters.comPatrick Lee | ReutersJanuary 3, 2024 | wsj.comGan & Lee Pharmaceuticals Co. Ltd. AJanuary 2, 2024 | msn.com3x NCAA Champion Spencer Lee Makes an Audacious Statement Regarding 1960’s Olympic MedalistNovember 21, 2023 | washingtonpost.comLee HockstaderApril 23, 2024 | TradeSmith (Ad)The A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...November 4, 2023 | investing.comLee’s Pharmaceutical Holdings Ltd (0950)November 3, 2023 | wsj.comLee's Pharmaceutical Holdings Ltd.October 26, 2023 | latimes.comWendy LeeOctober 10, 2023 | investing.comGan & Lee Pharmaceuticals Co Ltd (603087)May 15, 2023 | washingtonpost.comMichael LeeSee More Headlines Receive LPHM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lee Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/23/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Staples Industry Toilet preparations Sub-IndustryN/A Current SymbolOTCMKTS:LPHM Previous SymbolOTCMKTS:LPHM CUSIPN/A CIK58411 Webwww.leepharmaceuticals.com Phone(307) 278-1360Fax626-442-6994Employees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares35,162,000Free Float15,823,000Market Cap$21,097.20 OptionableNot Optionable Beta669.91 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Ronal Ford (Age 69)Founder, CEO & Chairman Mr. C.G. Ryche (Age 54)Chief Marketing Officer Dr. Delun WangSr. VP of Manufacturing & EngineeringMr. Damon Kuhn (Age 60)Chief Product Engineer & Product Manufacturing Integration Ms. Sheila R. StewartChief Global Corp. StrategistKey CompetitorsAlkaline WaterNASDAQ:WTERTattooed ChefNASDAQ:TTCFQMusclePharmOTCMKTS:MSLPCCA IndustriesOTCMKTS:CAWWDS Healthcare GroupOTCMKTS:DSKXView All Competitors LPHM Stock Analysis - Frequently Asked Questions How have LPHM shares performed in 2024? Lee Pharmaceuticals' stock was trading at $0.0258 at the beginning of 2024. Since then, LPHM shares have decreased by 97.7% and is now trading at $0.0006. View the best growth stocks for 2024 here. How do I buy shares of Lee Pharmaceuticals? Shares of LPHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:LPHM) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lee Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
